Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Dong, Biao ^a   Duan, Xunbao ^a   Chow, Hoi Yee ^b   Chen, Lingxia ^a   Lu, Hui ^a   Wu, Wenman ^a   Hauck, Bernd ^c   Wright, Fraser ^c   Kapranov, Philipp ^d   Xiao, Weidong ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d St Laurent Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14 3 3 PROTEIN ZETA DELTA; ACIDIC LEUCINE RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY MEMBER A; ACTIN CYTOPLASMIC 1; CAPSID PROTEIN; CELL PROTEIN; CESIUM CHLORIDE; LIPOCORTIN 1; LIPOCORTIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NUCLEOLIN; NUCLEOPHOSMIN; PARVOVIRUS VECTOR; PODOCALYXIN LIKE PROTEIN 1; PROTEIN SET; RECOMBINANT ADENO ASSOCIATED VIRUS VECTOR; SINGLE STRANDED DNA BINDING PROTEIN MITOCHONDRIAL; SPLICING FACTOR ARGININE SERINE RICH 1; SPLICING FACTOR ARGININE SERINE RICH 4; UNCLASSIFIED DRUG; PROTEOME;

ADENO ASSOCIATED VIRUS; AMINO ACID SEQUENCE; ARTICLE; CENTRIFUGATION; CESIUM CHLORIDE GRADIENT CENTRIFUGATION; CONTROLLED STUDY; GEL ELECTROPHORESIS; GEL ELECTROPHORESIS LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; GENETIC ASSOCIATION; LIFE CYCLE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEOMICS; SEROTYPE; TRANSGENE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRUS LIFE CYCLE; WESTERN BLOTTING; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; PROCEDURES; REPRODUCIBILITY; STANDARDS;

BLOTTING, WESTERN; CAPSID PROTEINS; CHROMATOGRAPHY, LIQUID; DEPENDOVIRUS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84895444344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086453     Document Type: Article

References (28)

1. Muzyczka N, Berns K (2001) Parvoviridae: the viruses and their replication. Fields virology 2: 2327-2359.
2. Flotte T, Carter B, Conrad C, Guggino W, Reynolds T, et al. (1996) A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther 7: 1145-1159. (Pubitemid 26202733)
3. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, et al. (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248. (Pubitemid 351724453)
4. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, et al. (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12: 342-347. (Pubitemid 43355084)
5. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, et al. (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365: 2357-2365.
6. Gray SJ, Choi VW, Asokan A, Haberman RA, McCown TJ, et al. (2011) Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Curr Protoc Neurosci Chapter 4: Unit 4 17.
7. Grieger JC, Choi VW, Samulski RJ (2006) Production and characterization of adeno-associated viral vectors. Nat Protoc 1: 1412-1428.
8. Allay JA, Sleep S, Long S, Tillman DM, Clark R, et al. (2011) Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial. Hum Gene Ther 22: 595-604.
9. Lock M, Alvira MR, Wilson JM (2012) Analysis of particle content of recombinant adeno-associated virus serotype 8 vectors by ion-exchange chromatography. Hum Gene Ther Methods 23: 56-64.
10. Wright JF (2009) Transient transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther 20: 698-706.
11. Ayuso E, Mingozzi F, Montane J, Leon X, Anguela XM, et al. (2010) High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 17: 503-510.
12. Wright JF (2011) Adeno-associated viral vector manufacturing: keeping pace with accelerating clinical development. Hum Gene Ther 22: 913-914.
13. Murray S, Nilsson CL, Hare JT, Emmett MR, Korostelev A, et al. (2006) Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry. J Virol 80: 6171-6176. (Pubitemid 43849195)
14. Nash K, Chen W, Salganik M, Muzyczka N (2009) Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol 83: 454-469.
15. Van Vliet K, Mohiuddin Y, McClung S, Blouin V, Rolling F, et al. (2009) Adeno-associated virus capsid serotype identification: Analytical methods development and application. J Virol Methods 159: 167-177.
16. Wang J, Xie J, Lu H, Chen L, Hauck B, et al. (2007) Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc Natl Acad Sci U S A 104: 13104-13109. (Pubitemid 351737600)
17. Johnson JS, Samulski RJ (2009) Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J Virol 83: 2632-2644.
18. Qiu J, Brown KE (1999) A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology 257: 373-382. (Pubitemid 29393405)
19. Bevington JM, Needham PG, Verrill KC, Collaco RF, Basrur V, et al. (2007) Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions. Virology 357: 102-113. (Pubitemid 44820332)
20. Sanlioglu S, Benson PK, Yang J, Atkinson EM, Reynolds T, et al. (2000) Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol 74: 9184-9196.
21. Hansen J, Qing K, Srivastava A (2001) Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol 75: 4080-4090. (Pubitemid 32410120)
22. Aslanidi GV, Rivers AE, Ortiz L, Govindasamy L, Ling C, et al. (2012) High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. Vaccine 30: 3908-3917.
23. Zhong L, Li B, Jayandharan G, Mah CS, Govindasamy L, et al. (2008) Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology 381: 194-202.
24. Zhong L, Li B, Mah CS, Govindasamy L, Agbandje-McKenna M, et al. (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci U S A 105: 7827-7832. (Pubitemid 351872723)
25. Jayandharan GR, Zhong L, Li B, Kachniarz B, Srivastava A (2008) Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 15: 1287-1293.
26. Shen WY, Lai YK, Lai CM, Rakoczy PE (2004) Impurity of recombinant adeno-associated virus type 2 affects the transduction characteristics following subretinal injection in the rat. Vision Res 44: 339-348. (Pubitemid 37501030)
27. Duan X, Kelsen SG, Merali S (2008) Proteomic analysis of oxidative stress-responsive proteins in human pneumocytes: insight into the regulation of DJ-1 expression. J Proteome Res 7: 4955-4961.
28. Duan X, Kelsen SG, Clarkson AB Jr, Ji R, Merali S (2010) SILAC analysis of oxidative stress-mediated proteins in human pneumocytes: new role for treacle. Proteomics 10: 2165-2174.